Deeb Asma, Elkadry Ihab, Attia Salima, Al Suwaidi Hana, Obaid Laila, Schoenmakers Nadia A
J Pediatr Endocrinol Metab. 2016 Jul 1;29(7):801-6. doi: 10.1515/jpem-2015-0275.
Congenital hypothyroidism (CH) is caused by thyroid gland (TG) dysgenesis or inadequate thyroid hormone biosynthesis in a structurally normal gland. Different etiologies are known to be associated with various clinical, biochemical and imaging markers and a subset of cases have an underlying genetic basis. Despite the presence of neonatal screening programs in the UAE, there is a lack of data on the disease etiology in the area. We aim to study the etiology of CH in our center and examine its relationship with the clinical, biochemical, genetic and radiological features.
Patients with CH who were followed in our center between 2011 and 2014 are enrolled in the study. Data collected included gender, gestational age, history of CH in a first-degree relative, initial thyroid stimulating hormone (TSH) and thyroxine (T4) levels, imaging findings, associated disease/malformation and treatment details. Selected patients with associated systemic disease or familial CH underwent genetic testing.
Sixty-five patients were enrolled. Ten patients underwent genetic study: seven patients with associated congenital disease/malformation, one with a sibling and two with cousins with CH. Forty-nine subjects had technetium99 and/or ultrasound scans. Dyshormonogenesis was diagnosed in two-thirds of the patients. Three patients of 10 tested had likely causative genetic mutations; two homozygous thyroid peroxidase (TPO) and one heterozygous thyroid stimulating hormone receptor (TSHR) missense mutations.
Dyshormonogenesis is the commonest etiology in CH in the studied group. It is expected that genetic mutations are more prevalent in our region due to the nature of the CH etiology and the rate of high consanguinity rate.
先天性甲状腺功能减退症(CH)是由甲状腺(TG)发育不全或结构正常的甲状腺中甲状腺激素生物合成不足引起的。已知不同的病因与各种临床、生化和影像学标志物相关,并且一部分病例具有潜在的遗传基础。尽管阿联酋有新生儿筛查项目,但该地区缺乏关于该疾病病因的数据。我们旨在研究我们中心CH的病因,并检查其与临床、生化、遗传和放射学特征的关系。
纳入2011年至2014年在我们中心接受随访的CH患者。收集的数据包括性别、胎龄、一级亲属中CH的病史、初始促甲状腺激素(TSH)和甲状腺素(T4)水平、影像学检查结果、相关疾病/畸形和治疗细节。选定的患有相关全身性疾病或家族性CH的患者接受基因检测。
共纳入65例患者。10例患者进行了基因研究:7例伴有先天性疾病/畸形,1例有患CH的兄弟姐妹,2例有患CH的表亲。49名受试者进行了锝99和/或超声扫描。三分之二的患者被诊断为激素合成障碍。10例检测患者中有3例可能存在致病基因突变;2例为纯合甲状腺过氧化物酶(TPO)突变,1例为杂合促甲状腺激素受体(TSHR)错义突变。
在所研究的CH患者组中,激素合成障碍是最常见的病因。由于CH病因的性质和高近亲结婚率,预计基因突变在我们地区更为普遍。